Marcel Keller - Department Biology I, Ludwig-Maximilians-University Munich

基本信息

浏览量：5

职业迁徙

个人简介

Marcel Keller is a Postdoc at the Institute of Genomics, University of Tartu, Estonia, and Integrative Prehistory and Archeological Science, University of Basel, Switzerland.

研究兴趣

论文共 59 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Probing the Zooarchaeological Record Across Time and Space for Ancient Pathogens

Anne K. W. Runge, Ian Light-Maka,Ken Massy,Marcel Keller,Simon Trixl, Helja Kabral, Casey L. Kirkpatrick,Kirsten Bos,Jana Eger,Michal Ernée,René Kyselý,Michael Hochmuth,Dominik Poradowski,Aleksander Chrószcz,Norbert Benecke,David Daněček, Jana Klementová, Anatoli Nagler,Alexey A. Kalmykov,Anatoly R. Kantorovich,Vladimir E. Maslov,Andrey B. Belinskiy, Christina L. Scheib,Meda Toderaş,Svend Hansen,Philipp W. Stockhammer,Kai Kaniuth,Regina Uhl,Sabine Reinhold, Rosalind E. Gillis,Elizabeth A. Nelson,Kamilla Pawlowska,Felix M. Key

biorxiv（2025）

引用0浏览0引用

Discovery of the Clinical Candidate IDOR-1117-2520: A Potent and Selective Antagonist of CCR6 for Autoimmune Diseases

Emmanuel A. Meyer,Andrew L. Croxford,Carmela Gnerre,Paulina Kulig,Mark J. Murphy, Elise M. Jacob,Gabriel Schafer,Sylvia Richard-Bildstein,Hamed Aissaoui,Patrick Bouis,Eric A. Ertel,Ruben de Kanter,Marcel P. Keller, Urs Luthi,Eva Caroff

Journal of Medicinal Chemistryno. 10 (2024): 8077-8098

引用2浏览0WOS引用

A Refined Phylochronology of the Second Plague Pandemic in Western Eurasia

openalex（2023）

引用4浏览0引用

Ancient DNA Extract Purification (chunk Samples/high Volume) V1

Marcel Keller

openalex（2023）

引用0浏览0引用

Discovery of Clinical Candidate ACT-777991, a Potent CXCR3 Antagonist for Antigen-Driven and Inflammatory Pathologies

Emmanuel A. Meyer,Paivi Aanismaa,Eric A. Ertel, Eva Huhn,Daniel S. Strasser,Markus Rey,Mark J. Murphy,Marianne M. Martinic,Laetitia Pouzol,Sylvie Froidevaux,Marcel P. Keller,Eva Caroff

Journal of medicinal chemistry（2023）

引用4浏览0WOS引用

Design, Synthesis, and Pharmacological Evaluation of Benzimidazolo-thiazoles As Potent CXCR3 Antagonists with Therapeutic Potential in Autoimmune Diseases: Discovery of ACT-672125

Eva Caroff,Emmanuel A. Meyer,Paeivi Aanismaa,Sylvie Froidevaux,Marcel Keller,Luca Piali

JOURNAL OF MEDICINAL CHEMISTRY（2022）

引用3浏览0WOS引用

Dining in Tuva: Social Correlates of Diet and Mobility in Southern Siberia During the 2nd–4th Centuries CE

Marco Milella,Gino Caspari,Zita Laffranchi,Gabriele Arenz,Timur Sadykov,Jegor Blochin,Marcel Keller,Yulija Kapinus,Sandra Losch

American Journal of Physical Anthropologyno. 1 (2022): 124-139

引用6浏览0引用

Rekonstruktion Mikrobieller Evolution Durch Sequenzierung Alter DNA

Guellil Meriam,Keller Marcel

BIOspektrumno. 3 (2022): 287-290

引用0浏览0引用

In Vitro Characterization of Sphingosine 1-Phosphate Receptor 1 (S1P1) Expression and Mediated Migration of Primary Human T and B Cells in the Context of Cenerimod, a Novel, Selective S1P1 Receptor Modulator

Lisa Schlicher,Paulina Kulig, Audrey von Munchow,Mark J. Murphy,Marcel P. Keller

International Journal of Molecular Sciences（2022）

引用2浏览0WOS引用

Discovery and in Vivo Evaluation of ACT-660602: A Potent and Selective Antagonist of the Chemokine Receptor CXCR3 for Autoimmune Diseases

Emmanuel A. Meyer,Paeivi Aanismaa,Sylvie Froidevaux,Marcel Keller,Luca Piali,Eva Caroff

JOURNAL OF MEDICINAL CHEMISTRY（2022）

引用2浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn